Analgesic Rebound and
How to Reverse It (2002)
Alan M. Rapoport, MD (1, 2) and Marcelo E. Bigal,
MD, PhD (1,3)
(1) The New England Center for Headache, Stamford,
CT
(2) Department of Neurology, Columbia University College
of Physicians and Surgeons, New York, NY
(3) Department of Neurology, Albert Einstein College
of Medicine, Bronx, NY
In most clinical studies on Chronic Daily Headache,
overuse of analgesics or other acute care medication
figures prominently. A patient develops CDH after
consuming a critical dose of a single medication or
a combination of medications for an extended period
of time, which can range, according to the medication,
from 1 to 2 years (triptans) to 5 years (analgesics).
Occasionally it occurs much faster. Acute withdrawal
of the offending medication worsens headache for a
finite time, usually from 3 days to three weeks. Both
preventive and acute care treatment for the primary
headache complaint usually fail if the offending medication
or medications are not terminated.
Analgesic rebound headache (ARH) can, therefore be
defined as the perpetuation and increased intensity
of head pain in chronic headache sufferers, caused
by the frequent and excessive use of immediate relief
headache medications. A combination of pharmacological,
non-pharmacological, behavioral and sometimes physical
interventions is usually necessary for a favorable
outcome in ARH sufferers. Support programs and behavioral
medicine techniques are an important part in ensuring
treatment plan success. The essential features of
an effective treatment regimen include the following
steps:
Educate the patient:
Adequate instruction
about the biology of ARH, and the self-sustaining
and deleterious effects of certain medications used
in excessive quantities and at too frequent intervals.
The challenge lies in explaining to the patient that,
despite the fact that effective therapies for treating
these headaches do exist, it is essential to first
reduce the levels of overused medications, or withdraw
them completely, which may cause discomfort for as
long as 3 or 8 weeks. Without a thorough understanding
of whey they need to endure this short-term pain for
long term gain, the patient is unlikely to be compliant.
Establish expectations
and a follow-up plan:
Patients who overuse acute care medication may not
become fully responsive to acute and preventive treatment
for 3-8 weeks and possibly as long as 12 weeks after
overuse is eliminated.
Support the patient.
Tell them you believe
they are overusing medication just to be able to function
and speak to their families, employer or school personnel
if necessary.
Use non-pharmacological
therapies: A number
of non-pharmacological measures help to overcome the
physiological component of analgesic rebound. In addition,
they help to empower the patient in his or her own
therapeutic course. Useful modalities include:
- Biofeedback and relaxation therapy
- Cognitive behavioral therapy
- Individual / family counseling as necessary
- Dietary instructions
- Chronobiologic therapy and sleep hygiene
- Daily exercise program
- Physical therapy and other physical techniques such
as
acupuncture, acupressure, cranio-sacral therapy and
manipulation (where and when appropriate)
- Trial of large doses of magnesium and vitamin B2
orally
Discontinue all
potentially offending medications and
caffeine by gradual outpatient or inpatient detoxification
procedures. This is probably the most important step.
Patients must understand that the treatment will not
be effective if they continue overusing acute medications.
Institute a program of
acute care and preventive pharmacological therapy
to avoid the setting in which analgesic rebound may
recur.
The great majority of patients who present with CDH
are overusing acute care medications. Implementing
a successful treatment plan begins with educating
the patient about their illness and possible contributing
factors. An effective support system must be established
so the patient does not fall back into the same patterns
of overuse. Non-pharmacological therapies are often
essential and multiple acute care and preventive medications
are usually prescribed. When treated intensively and
properly, there is an 85% chance of significant improvement.
Return
to lead articles index page